Table 1.
Study | Age/Gender | Pre- history | Location | Concomitant symptoms |
Visual prognosis | Final diagnosis | Medical management |
---|---|---|---|---|---|---|---|
Bouhout et al. | 59/ female |
T2DM | Right | Endophthalmitis & orbital cellulitis | Eye removed | EE | IV meropenem (2 g TID) IV ceftriaxone (2 g BID) PO ciprofloxacin (500 mg BID) PO prednisone PO amoxicillin-clavulanic (875 mg BID) IV ceftriaxone (2 g DIE) PO prednisone (30 mg daily as determined by clinical improvement) |
Chiba et al. |
79/ female |
NA | Right | Ventriculitis | Eye removed | EE | NA |
Lee et al. |
56/ female |
NA | Left | RON | LP | RON | IV ceftriaxone and moxifloxacin (for 20 days) IV dexamethasone (20 mg daily followed by oral prednisolone) |
Key: ON: optic neuritis; K. pneumoniae: Klebsiella pneumoniae; T2DM: Type 2 diabetes mellitus; EE: Endogenous endophthalmitis; IV: intravenous; TID: three times per day; BID: two times per day; PO: per os (by mouth); DIE: daily; RON: Para-infectious optic neuritis; LP: Light perception; NA: Not available.